Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Structure‐Based Design of a Monosaccharide Ligand Targeting Galectin‐8
Beteiligte:
Bohari, Mohammad H.;
Yu, Xing;
Kishor, Chandan;
Patel, Brijesh;
Go, Rob Marc;
Eslampanah Seyedi, Hadieh A.;
Vinik, Yaron;
Grice, I. Darren;
Zick, Yehiel;
Blanchard, Helen
Erschienen:
Wiley, 2018
Erschienen in:ChemMedChem
Sprache:
Englisch
DOI:
10.1002/cmdc.201800224
ISSN:
1860-7179;
1860-7187
Entstehung:
Anmerkungen:
Beschreibung:
<jats:title>Abstract</jats:title><jats:p>Galectin‐8 is a β‐galactoside‐recognising protein that has a role in the regulation of bone remodelling and is an emerging new target for tackling diseases with associated bone loss. We have designed and synthesised methyl 3‐<jats:italic>O</jats:italic>‐[1‐carboxyethyl]‐β‐<jats:sc>d</jats:sc>‐galactopyranoside (compound <jats:bold>6</jats:bold>) as a ligand to target the N‐terminal domain of galectin‐8 (galectin‐8<jats:italic>N</jats:italic>). Our design involved molecular dynamics (MD) simulations that predicted <jats:bold>6</jats:bold> to mimic the interactions made by the galactose ring as well as the carboxylic acid group of 3′‐<jats:italic>O</jats:italic>‐sialylated lactose (3′‐SiaLac), with galectin‐8<jats:italic>N</jats:italic>. Isothermal titration calorimetry (ITC) determined that the binding affinity of galectin‐8<jats:italic>N</jats:italic> for <jats:bold>6</jats:bold> was 32.8 μ<jats:sc>m</jats:sc>, whereas no significant affinity was detected for the C‐terminal domain of galectin‐8 (galectin‐8<jats:italic>C</jats:italic>). The crystal structure of the galectin‐8<jats:italic>N</jats:italic>–<jats:bold>6</jats:bold> complex validated the predicted binding conformation and revealed the exact protein–ligand interactions that involve evolutionarily conserved amino acids of galectin and also those unique to galectin‐8<jats:italic>N</jats:italic> for recognition. Overall, we have initiated and demonstrated a rational ligand design campaign to develop a monosaccharide‐based scaffold as a binder of galectin‐8.</jats:p>